Altrartis Therapeutics
Altrartis Therapeutics reported $10,999,977 raised in an SEC Form D filed on 2026-10-22. State of the filing: New York.
- Industry
- Other
- Location
- New York
About
Altrartis Therapeutics filed an SEC Form D on 2026-10-22. The filing reports $10,999,977 raised and gives New York as the state. The industry on the filing is Other. Related persons named on the filing: Florian Brand (executive officer, director, promoter, New York, New York); Lars Christian Wilde (director, New York, New York). The legal name on the form is Altrartis Therapeutics Inc. Filing: https://www.sec.gov/Archives/edgar/data/2157050/000123191926001488/0001231919-26-001488-index.htm
This is the issuer's first Form D in the EDGAR submissions list read here.
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-22 | $11M |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2157050/000123191926001488/0001231919-26-001488-index.htm
Type: sec filing. Accessed 2026-10-26.
SEC Form D for Altrartis Therapeutics Inc. EDGAR filing date 2026-10-22. Signed 2026-10-22 by Florian Brand. First sale 2026-08-12. Total amount sold $10,999,977 of an offering amount of $10,999,977. 11 investors already invested. Issuer address city is New York, New York. Jurisdiction on the form: Delaware. Year of incorporation on the form: 2025. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. The form describes the securities as equity. This is the issuer's first Form D in the EDGAR submissions list read here.